Accelerate Diagnostics Inc expected to post a loss of 15 cents a share - Earnings Preview

Accelerate Diagnostics

27/03/2023 21:58

* Accelerate Diagnostics Inc  AXDX.OQ   AXDX.O  is expected
to show a fall in quarterly revenue when it reports  results on
March 29. 
    * The Denver Colorado-based  company is expected to report 
a
14.1% decrease in revenue to $2.872 million from $3.34 million a
year ago, according to the mean estimate from 2 analysts, based
on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Accelerate
Diagnostics
Inc is for a loss of 15 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Accelerate
Diagnostics Inc is $2​, above​ its last closing price of $0.49.
​​​

This summary was machine generated March 27 at 20:58 GMT.  All
figures in US dollars  unless otherwise stated